Journal of fish pathology (한국어병학회지)

The Korean Society of Fish Pathology (한국어병학회)
권호 표지

Distribution of Quinolones (Ciprofloxacin, Norfloxacin and Oxolinic acid) after Oral Administration in Carp (Cyprinus carpio)

잉어에 있어서 Quinolones (Ciprofloxacin, Norfloxacin 및 Oxolinic acid)의 경구투여에 따른 장기내 분포상

  • Choi, Min-Soon (Department of Aqualife Medicine, Kunsan National University) ;
  • Park, Kwan-Ha (Department of Aqualife Medicine, Kunsan National University)
  • 최민순 (군산대학교 해양과학대학 수산생명의학과) ;
  • 박관하 (군산대학교 해양과학대학 수산생명의학과)
  • Published : 20051200
Download PDF
⟨ Previous Next ⟩

Abstract

The concentrations of quinolones (oxolinic acid; OXA, norlloxacin: NRF & ciprofloxacin: CPF) after oral administration of single doses (20 mg/kg B.W.) were investigated in carp (Cyprinus carpio) kept in freshwater at 20-23$^{\circ}C$. The distribution of the drug was studied after treatment. At points timed, from 1 h to 96 hrs after administration, blood (B), liver (L), kidney (K) and muscle (M) from 5 individuals in each group were collected for analyse with microbiological bioassay method. The peak concentrations were measured at 8 h (L), 12 h (B and K) and 24 h (M) after administration regardless of treated drugs. Considerably high concentrations of CPF (13.8-19.6${\mu}g/m{\ell}$) NRF (11.8-16.9${\mu}g/m{\ell}$) and OXA (10.8-13.9 ${\mu}g/m{\ell}$) were revealed during the 24 h. At the last time point of the experiment (96 h), concentrations of all three quinolones were: OXA, 2.3-6.3 ${\mu}g/m{\ell}$ ; NRF, 3.1-4.5 ${\mu}g/m{\ell}$ ; CPF, 3.0-5.5${\mu}g/m{\ell}$ in samples. The concentrations decreased subsequently, indicating a first rapid redistribution, followed by a slow phase of elimination. The steady state was observed in blood (12-36 h), liver (12-96 h) and muscle (36-96 h) after the initiation of treatment with OXA. Concerning the compartmental concentrations, (L, K. and M/B concentration ratio), the fluctuation of the ratio was founded at different time points, among drugs. For CPF, highest tissue ratios were prolonged in the order of L>K>M (0.65-1.2/0.82-0.93/1.0-1.7) during the experiments. On the other hand, NRF presented L>K>M (0.65-1.3/0.86-1.0) till 24 h, but L>M>K (0.89-1.26) at 36-96 h. OXA showed L>K>M (0.95-2.1) at 1-8 h, M>K>L (0.51-1.0) at 12-36 hand M>L>K (1.0-2.3) at 48-96 h, respectively.

본 실험에서 잉어를 대상으로 CPF, NRF 및 OXA등의 약제를 어체당 20 mg/kg 현탁액을 경구투여 후에 1-96 시간 경시적으로 약물의 동태를 조사 하였다. 각 약제별 최고장기농도도달시간은 간장 (8 h), 혈액 (12 h), 신장(12 h) 및 근육 (24 h) 이었다. 각 약제별 최대농도는 CPF (13.8-19.6 ${\mu}g$/$m\ell$), NRF (11.8-15.9 ${\mu}g$/$m\ell$), 및 OXA (10.8-13.9 ${\mu}g$/$m\ell$)순으로 나타났다. 약제농도는 최고치의 도달 이후 빠르게 소실되다가 48-96 h는 완만한 감소를 보였으며, 이때 장기별 약제농도는 근육 (3.3-6.3 ${\mu}g$/$m\ell$)> 간장 (2.5-5.5 ${\mu}g$/$m\ell$)> 신장 (2.3-4.2 ${\mu}g$/$m\ell$) > 혈장 (2.1-3.0 ${\mu}g$/$m\ell$)순으로 나타났다. 한편, OXA의 경우 다른 약제에 비해서 약물의 정체기가 나타났다. 즉 혈중은 12-36 h;, 고농도저류대 (24 hr; 10.9-8.8 ${\mu}g$/$m\ell$), 근육은 36-96 h에 중간농도대 (60 hr; 8.5-5.8 ${\mu}g$/$m\ell$) 및 간장은 12-96 h에 저농도대 (84 hr; 6.8-3.3 ${\mu}g$/$m\ell$)등이 형성되었다.약제의 혈중농도에 대한 각 장기농도비 (간장;L, 신장;K, 및 근육;M / 혈액;B)는 시간대에 따라 차이를 보였다. CPF는 즉 L>K>M (0.65-1.2/0.82-0.93/1.0-1.7)순으로 시간대별로 차이가 없었다. NRF는 시간대별로 1-8 h 및 12-24 h L>K>M (0.65-1.3/0.86-1.0)순이었으나, 36 h 이후 L>M>K (0.89-1.26)순이었다. OXA의 있어서는 1-8 h에는 L>K>M (0.95-2.1), 12-36에는 M>K>L (0.51-1.0) 및 48-96 h에는 M>L>K (1.0-2.3)으로 나타났다.

Keywords

References

  1. Alderman, D. J.: Fisheries chemotheraphy: a review, In 'recent advances in aquaculture'(ed by J. M. Muir and Roberts R. J.) Croom Helm. London, 3: 1-61. 1988
  2. Barnes, A. C., Lewins, T. S, Hastings, T. S. and Arnyes, S. G.: In vitro activities of 4- quinolones against the fish pathogen Aeromonas sul monicida. Antimicrob. Agents Chernother., 34: 1819-1820, 1990 https://doi.org/10.1128/AAC.34.9.1819
  3. Barnes, A. C, Amyes S. G. B., Hasting, T. S. and Lewin C. S.: Fiuroquinolones display rapid bactericidal activity and low mutation frequency against Aeromonas salmonicida. J. Fish Dis., 14: 661-667,1991 https://doi.org/10.1111/j.1365-2761.1991.tb00624.x
  4. Choi, M. S., Kim, K. H., Seo, Y .H., Choi, S. H. and Park, K. H.: Antibacterial activity of new quinolones against Edwardsiella tarda isolated from eel tanks. J. Fish Pathol., 9(2): 185-193, 1996
  5. Ellingen, O. F, Midttun, B., Rogstad, A., Syversten, C. and samuelsen O. B.: Dosage regime experiments with oxolinic acid and flumequine in Atlantic salmon(Salmo salar) held in sea water. Aquaculture, 209: 19-34, 2002 https://doi.org/10.1016/S0044-8486(01)00804-3
  6. Hae, G. J., Park, S. C. and Kim, D. W.: A study on efficacy and safety of quinolone antibacterial (Ciprotloxacin) to bacterial disease in cultured fish, Cyprinus carpio and Oncorhynchus mykiss. Kor. J. Vet. Publ. Health, 22(2): 176-186, 1998
  7. Intorre, L., Ceechini, S., Cognetti- Varriale, A. M., Soldani, G. and Mengozzi, G.: Pharmacokinetics of enrotloxacin in the seabass (Dicentrarchus labraxi. Aquaculture, 182: 49-59, 2000 https://doi.org/10.1016/S0044-8486(99)00253-7
  8. Ishida, N.: Tissue levels of oxolinic acid after oral or intravascular administration to fresh water and seawater rainbow trout. Aquaculture, 102: 9-15,1992 https://doi.org/10.1016/0044-8486(92)90284-R
  9. Kim J. W., lung, S. H., Lee, J. S., Choi, D. L., and Jo, M. R.: Effects of temperature on the pharmacokinetics of norfloxacin in Carp (Cyprinus carpio) and Eel (Anguilla japonica).J. Fish Pathol., 15(2): 49-56, 2002
  10. Lewin, C. S., Allen, R. A. and Amyes, G. G. B.: Potential mechanism of resistance to modern tluoroquinated 4-quinolone. J. Med. microbiol., 31: 153-161, 1990 https://doi.org/10.1099/00222615-31-3-153
  11. Lewin, C. S. and Hastings, T S.: In vitro activities of oxolinic acid, ciprofloxacin and nortloxacin against of the A. saltnonicida. J. Fish Dis., 13: 377-384,1990 https://doi.org/10.1111/j.1365-2761.1990.tb00796.x
  12. Martinsen, B., Myhr, E, Reed, E and Hasten, T: In vitro antimicrobial activity of sarafloxacin against clinical isolates of bacteria pathogenic to fish. J. Aquat. Anim. Health, 3: 235-241, 1991 https://doi.org/10.1577/1548-8667(1991)003<0235:IVAAOS>2.3.CO;2
  13. Martinsen, B. Horsberg, T E and Burke, M.: Multiple-dose pharmacokinetic and depletion studies of saratloxsacin in Atlantic salmon (Salmo salar L). J. Fish Dis., 17: 111-121. 1994 https://doi.org/10.1111/j.1365-2761.1994.tb00204.x
  14. Nouws, J. F. M., Grondel, J. L., Schutte, A. R. and Laurenseri, J.: Pharmacokinetics of ciprotloxacin in carp, African carp and R. trout. Vet. Quart., 10(3): 211-216, 1998
  15. Rogstad, A., Ellingsen, O. F. and Syversten, C.: Pharmacokinetics and bioavailability of flumequin and oxolinic acid after various routes of administration to Atlantic salmon in seawater. Aquaculture, 110: 207-220, 1993 https://doi.org/10.1016/0044-8486(93)90369-A
  16. Rocca, G. D., Salvo, A. D., Malvis, J. and Sello, M.: The distribution of enrotloxacin in seabream after single intravenous injection or from medicated feed administration. Aquaculture, 232: 53-62, 2004 https://doi.org/10.1016/S0044-8486(03)00455-1
  17. Samuelsen, O. B., Ervik, A., Pursell, L. and Smith, P.: Single dose pharmacokinetic study of oxolinic acid and vetoquinol, an oxolinic acid ester, In Atlantic salmon (Salmo salarv held in seawater and in vitro antibacterial activity againstA. salmonicida. Aquaculture, 18: 213-224, 2000
  18. Smith, J. T. and Lewin, C. S.: Chemistry and mechanicals of action of the quinolones antibacterial. In 'The Quinolones'(ed by Andriole, V. T). Academic press, London, pp. 23-82, 1988
  19. Stamm, J. M.: In vitro resistance by fish pathogens to aquacultural antibacterials, including the quinolones difloxacin (A-56619) and saratloxacin (A-56620). J. Aquat. Anim, Health, 1: 135-141,1989 https://doi.org/10.1577/1548-8667(1989)001<0135:IVRBFP>2.3.CO;2
  20. Stoffregen, D. A., Wooster, G. A., Bustos, P. S., Bowser, P. R. and Babish, J. G.: Multiple route and dose pharmacokinetics of enrofloxacin in juvenile Atlantic salmon. J. Vet. Pharmacol. Ther., 20: 111-123, 1997 https://doi.org/10.1046/j.1365-2885.1997.81531.x
  21. Treves, B. K. M.: Applied Fish Pharmacology. Kluwer academic pub., pp. 56-63,2000
  22. Waterworth, P. M.: Quantitative methods for bacterial sensitivity testing. In review, D. S., Philips, I., Williams, J. D. Wise, R. (eds), Laboratory methods in antimicrobial chemotherapy. Livinstone, Edinburgh, pp. 31-40, 1978
  23. Wolfson, J. S. and Hooper, D. C.: The tluroquinolones: Structures, mechanism of action and resistance, and spectra of activity in vitro. Antimicrob. Agents Chemother., 28(4): 1647-1650,1985
  24. 정승희, 지보영, 이주석, 도정환, 최동림, 김진우, 박미선: 어류질병 진단 및 치료대책, 해수부, pp, 110-118. 2000